IL-8, GRO and MCP-1 produced by hepatocellular carcinoma microenvironment determine the migratory capacity of human bone marrow-derived mesenchymal stromal cells without affecting tumor aggressiveness.

ESTEBAN FIORE; MARCELA BOLONTRADE; CRISTÓBAL FRESNO; MANUEL GIDEKEL; JUAN BAYO; MARIANA MALVICINI; JUAN BAYO; ADRIANI OSCAR; MARIANA MALVICINI; ALEJANDRINA REAL; OSVALDO PODHAJCER; ADRIANI OSCAR; LEONARDO SGANGA; GUILLERMO D. MAZZOLINI; OSVALDO PODHAJCER; CAROLINA BIZAMA; GUILLERMO D. MAZZOLINI; ELMER FERNANDEZ; ALEJANDRINA REAL; MARIANA G. GARCÍA; LEONARDO SGANGA; ESTEBAN FIORE; CAROLINA BIZAMA; MARCELA BOLONTRADE; ELMER FERNANDEZ; CRISTÓBAL FRESNO; MARIANA G. GARCÍA; MANUEL GIDEKEL

oncotarget

Impact Journals

Lugar: Nueva York ; Año: 2016

1949-2553

New therapies are needed for advanced hepatocellular carcinoma (HCC) and the use of mesenchymal stromal cells (MSCs) carrying therapeutic genes is a promising strategy. HCC produce cytokines recruiting MSCs to the tumor milieu and modifying its biological properties. Our aim was to study changes generated on human MSCs exposed to conditioned media (CM) derived from human HCC fresh samples and xenografts. All CM shared similar cytokines expression pattern including CXCL1-2-3/GRO, CCL2/MCP-1 and CXCL8/IL-8 being the latter with the highest concentration. Neutralizing and knockdown experiments of CCL2/MCP-1, CXCL8/IL-8, CXCR1 and CXCR2 reduced in vitro MSC migration of ≥20%. Simultaneous CXCR1 and CXCR2 neutralization resulted in 50% of MSC migration inhibition. MSC stimulated with CM (sMSC) from HuH7 or HC-PT-5 showed a 2-fold increase of migration towards the CM compared with unstimulated MSC (usMSC). Gene expression profile of sMSC showed ~500 genes differentially expressed compared with usMSC, being 46 genes related with cell migration and invasion. sMSC increased fibroblasts and endothelial cells chemotaxis. Finally, sMSC with HuH7 CM and then inoculated in HCC tumor bearing-mice did not modify tumor growth. In this work we characterized factors produced by HCC responsible for the changes in MSC chemotactic capacity with would have an impact on therapeutic use of MSCs for human HCC.